Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138178492> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2138178492 abstract "Although aspirin is one of our oldest pharmacological agents and much is known about it, our understanding of the particulars of its use as a preventive measure for cardiovascular disease (CVD) still resides in the domain of debate. Clearly, aspirin does offer some benefit in reducing the risk of CVD, but questions remain regarding the choice of patients and the optimal dose.Patients with diabetes comprise a special population and are often prescribed aspirin for its potential cardiovascular risk-reductive action. This brief article reviews the use of aspirin in this population as a primary preventive measure. It focuses on several recently released position statements, including one recently co-issued by the American Diabetes Association (ADA), the American Heart Association (AHA), and the American College of Cardiology Foundation (ACCF).Salicin, a natural precursor of aspirin found in willow bark and leaves, was used during the time of Hippocrates (400 BC) for the attenuation of pain and as an anti-pyretic.1 In the 1800s, aspirin was synthesized from the spirea plant (which is rich in salicin), and by 1899, the Bayer pharmaceutical company was distributing aspirin to physicians for use in their patients.Aspirin was typically used for the management of pain, fever, and inflammation, but in 1948, Dr. Lawrence Craven, using only his intuition and empirical observations, noted that his patients treated with aspirin did not suffer heart attacks. Based on this notion, he routinely prescribed aspirin to his patients as a preventive measure.2 Ironically, in 1957, Craven died at the age of 74 of a myocardial infarction (MI), while denying himself aspirin therapy because he fell out of the age range that he felt benefited from treatment (45–65 years). It is interesting to note that his initial recommendations were fairly consistent with today's data-based recommendations.The elucidation of aspirin's mechanisms …" @default.
- W2138178492 created "2016-06-24" @default.
- W2138178492 creator A5057977258 @default.
- W2138178492 date "2011-02-01" @default.
- W2138178492 modified "2023-09-24" @default.
- W2138178492 title "Primary Prevention of Cardiovascular Events With Aspirin in Patients With Diabetes" @default.
- W2138178492 cites W1518382227 @default.
- W2138178492 cites W2024352468 @default.
- W2138178492 cites W2063190337 @default.
- W2138178492 cites W2161582050 @default.
- W2138178492 cites W2461576233 @default.
- W2138178492 cites W2596624061 @default.
- W2138178492 cites W1900625924 @default.
- W2138178492 doi "https://doi.org/10.2337/diaspect.24.1.47" @default.
- W2138178492 hasPublicationYear "2011" @default.
- W2138178492 type Work @default.
- W2138178492 sameAs 2138178492 @default.
- W2138178492 citedByCount "0" @default.
- W2138178492 crossrefType "journal-article" @default.
- W2138178492 hasAuthorship W2138178492A5057977258 @default.
- W2138178492 hasConcept C126322002 @default.
- W2138178492 hasConcept C134018914 @default.
- W2138178492 hasConcept C177713679 @default.
- W2138178492 hasConcept C2777628954 @default.
- W2138178492 hasConcept C2779134260 @default.
- W2138178492 hasConcept C2780220376 @default.
- W2138178492 hasConcept C2908647359 @default.
- W2138178492 hasConcept C555293320 @default.
- W2138178492 hasConcept C71924100 @default.
- W2138178492 hasConcept C86803240 @default.
- W2138178492 hasConcept C89423630 @default.
- W2138178492 hasConcept C99454951 @default.
- W2138178492 hasConceptScore W2138178492C126322002 @default.
- W2138178492 hasConceptScore W2138178492C134018914 @default.
- W2138178492 hasConceptScore W2138178492C177713679 @default.
- W2138178492 hasConceptScore W2138178492C2777628954 @default.
- W2138178492 hasConceptScore W2138178492C2779134260 @default.
- W2138178492 hasConceptScore W2138178492C2780220376 @default.
- W2138178492 hasConceptScore W2138178492C2908647359 @default.
- W2138178492 hasConceptScore W2138178492C555293320 @default.
- W2138178492 hasConceptScore W2138178492C71924100 @default.
- W2138178492 hasConceptScore W2138178492C86803240 @default.
- W2138178492 hasConceptScore W2138178492C89423630 @default.
- W2138178492 hasConceptScore W2138178492C99454951 @default.
- W2138178492 hasLocation W21381784921 @default.
- W2138178492 hasOpenAccess W2138178492 @default.
- W2138178492 hasPrimaryLocation W21381784921 @default.
- W2138178492 hasRelatedWork W1968803370 @default.
- W2138178492 hasRelatedWork W1979658733 @default.
- W2138178492 hasRelatedWork W2002023598 @default.
- W2138178492 hasRelatedWork W2010545601 @default.
- W2138178492 hasRelatedWork W2024798652 @default.
- W2138178492 hasRelatedWork W2063615929 @default.
- W2138178492 hasRelatedWork W2092632167 @default.
- W2138178492 hasRelatedWork W2148443271 @default.
- W2138178492 hasRelatedWork W2348951233 @default.
- W2138178492 hasRelatedWork W2422843152 @default.
- W2138178492 hasRelatedWork W2531454911 @default.
- W2138178492 hasRelatedWork W2773170895 @default.
- W2138178492 hasRelatedWork W2912200845 @default.
- W2138178492 hasRelatedWork W2943693578 @default.
- W2138178492 hasRelatedWork W2943728788 @default.
- W2138178492 hasRelatedWork W2964799330 @default.
- W2138178492 hasRelatedWork W2967334932 @default.
- W2138178492 hasRelatedWork W2982388763 @default.
- W2138178492 hasRelatedWork W3038117102 @default.
- W2138178492 hasRelatedWork W3144204937 @default.
- W2138178492 isParatext "false" @default.
- W2138178492 isRetracted "false" @default.
- W2138178492 magId "2138178492" @default.
- W2138178492 workType "article" @default.